Abstract:In this work, we developed ultrasound-responsive and injectable hydrogels for local and on-demand release of chemotherapeutics to solid tumors. Injectable hydrogels were prepared by using a zwitterionic monomer, sulfobetaine methacrylate (SBMA), without using any crosslinker. Gelation was performed at -20 oC using APS/TEMED as initiator, allowing the formation of strong electrostatic interactions between poly(SBMA) chains to physically crosslink the hydrogels. Monomer and initiator concentrations were carefully optimized to achieve injectable hydrogels with mechanical and thermal stability. To render ultrasound responsivity to the hydrogels, we loaded the hydrogels with hydrophobically (dodecyl) modified mesoporous silica nanoparticles (hMSNs) with sizes around 50 nm. When insonated with low-intensity focused ultrasound (LIUS), the hMSNs incept acoustic cavitation (i.e., growth and collapse of microsized bubbles), which in turn generates mechanical effects in the hydrogels such as shock waves or water jets. We found that loading the hydrogels with hMSN did not affect their injectability, and they remained mechanically stable at 37 °C for more than a week. hMSN-loaded hydrogels demonstrated strong ultrasound responsivity even at low particle concentrations (0.1 mg/mL) and ultrasound powers (25 W, 0.02% duty cycle). Finally, we loaded the hydrogels with a chemotherapy drug, doxorubicin (DOX, 0.2 mg/mL). DOX-loaded hydrogels demonstrated minimal release without LIUS treatment (<20% in a day). Application of LIUS (150 W, 1% duty cycle) for 5 min resulted in almost complete mechanical disintegration of the hydrogels, resulting in a burst DOX release. We also showed that the amount of released DOX could be controlled by tuning the LUIS power and its duration. In summary, we developed injectable hydrogels with strong ultrasound responsivity. These hydrogels hold great promise for local and on-demand drug delivery to solid tumors, which is currently under investigation in our laboratory. Citation Format: Li Xiang, Gulsu Sener, Adem Yildirim. Ultrasound responsive injectable hydrogels for on-demand drug delivery [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5751.

In Situ Floating Hydrogel for Intravesical Delivery of Adriamycin Without Blocking Urinary Tract

Floating Hydrogel With Self-Generating Micro-Bubbles For Intravesical Instillation

A Floating Hydrogel System Capable of Generating CO2 Bubbles to Diminish Urinary Obstruction after Intravesical Instillation

Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release.

Long-Term Retention Microbubbles with Three-Layer Structure for Floating Intravesical Instillation Delivery.

Polysaccharide based supramolecular injectable hydrogels for in situ treatment of bladder cancer

Encapsulation of hydroxycamptothecin within porous and hollow poly(l-lactide- co -ε-caprolactone) microspheres as a floating delivery system for intravesical instillation

Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.

A Facile Strategy For In Situ Controlled Delivery Of Doxorubicin With A Ph-Sensitive Injectable Hydrogel

In situ Hydrogels Prepared by Photo-initiated Crosslinking of Acrylated Polymers for Local Delivery of Antitumor Drugs

Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery

Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation via Thiol-Maleimide Click Reaction for Intravesical Drug Delivery

A mucoadhesive-to-penetrating nanomotors-in-hydrogel system for urothelium-oriented intravesical drug delivery

In Situ Gelation of Supramolecular Hydrogel for Anti-Tumor Drug Delivery.

Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer

Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.

Intravesical Hydrogels As Drug Reservoirs

Biodegradable ring-shaped implantable device for intravesical therapy of bladder disorders

One-Step In Situ Self-Assembly of Biodegradable Films for Long-Term Intravesical Bladder Cancer Therapy

Abstract 5751: Ultrasound responsive injectable hydrogels for on-demand drug delivery

In Situ Injection of Phenylboronic Acid Based Low Molecular Weight Gels for Efficient Chemotherapy